| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 6 | 2021 | 254 | 0.770 |
Why?
|
| Blood Group Incompatibility | 2 | 2018 | 39 | 0.750 |
Why?
|
| ABO Blood-Group System | 2 | 2018 | 124 | 0.730 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 39 | 0.610 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2016 | 111 | 0.600 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 266 | 0.560 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 73 | 0.500 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1191 | 0.490 |
Why?
|
| Rare Diseases | 3 | 2017 | 358 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 5774 | 0.360 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 7014 | 0.360 |
Why?
|
| Mutation | 8 | 2024 | 15908 | 0.350 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 697 | 0.310 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 23 | 0.310 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 433 | 0.280 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 183 | 0.280 |
Why?
|
| Heterozygote | 2 | 2022 | 1056 | 0.280 |
Why?
|
| Protein Subunits | 1 | 2018 | 279 | 0.280 |
Why?
|
| Infant | 17 | 2023 | 13939 | 0.270 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 198 | 0.270 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 140 | 0.270 |
Why?
|
| Coatomer Protein | 2 | 2016 | 33 | 0.260 |
Why?
|
| Syndrome | 4 | 2023 | 1406 | 0.240 |
Why?
|
| Child | 22 | 2023 | 30496 | 0.240 |
Why?
|
| Genome, Human | 2 | 2018 | 1885 | 0.240 |
Why?
|
| Exome | 3 | 2022 | 1249 | 0.240 |
Why?
|
| Child, Preschool | 15 | 2023 | 16999 | 0.240 |
Why?
|
| Virus Diseases | 2 | 2019 | 392 | 0.230 |
Why?
|
| Infant, Newborn | 9 | 2022 | 8626 | 0.230 |
Why?
|
| Ikaros Transcription Factor | 1 | 2023 | 53 | 0.220 |
Why?
|
| Alleles | 2 | 2018 | 2591 | 0.220 |
Why?
|
| Replication Protein A | 1 | 2022 | 37 | 0.200 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 68 | 0.200 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 462 | 0.200 |
Why?
|
| Telomere Shortening | 1 | 2022 | 56 | 0.190 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 8 | 0.190 |
Why?
|
| Hearing Loss | 1 | 2023 | 173 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2023 | 249 | 0.190 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 12 | 0.190 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 50 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 133 | 0.180 |
Why?
|
| Interferon Type I | 2 | 2021 | 282 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2017 | 2165 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 203 | 0.180 |
Why?
|
| Fibrinogen | 1 | 2021 | 213 | 0.170 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 372 | 0.170 |
Why?
|
| Software | 1 | 2017 | 1389 | 0.170 |
Why?
|
| Anaphylaxis | 1 | 2021 | 123 | 0.170 |
Why?
|
| Humans | 43 | 2024 | 270457 | 0.170 |
Why?
|
| I-kappa B Kinase | 2 | 2022 | 248 | 0.170 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2019 | 1 | 0.170 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 202 | 0.170 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 190 | 0.160 |
Why?
|
| Microcephaly | 1 | 2022 | 333 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1068 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 1280 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 221 | 0.160 |
Why?
|
| Telomere | 1 | 2022 | 549 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2023 | 845 | 0.150 |
Why?
|
| Male | 22 | 2024 | 128105 | 0.150 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2019 | 84 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 25 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 112 | 0.150 |
Why?
|
| Alemtuzumab | 1 | 2018 | 213 | 0.150 |
Why?
|
| Arthritis | 2 | 2016 | 147 | 0.140 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 235 | 0.140 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 385 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2018 | 234 | 0.140 |
Why?
|
| Base Sequence | 2 | 2018 | 5434 | 0.140 |
Why?
|
| Metapneumovirus | 1 | 2017 | 57 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 2572 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 72 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2019 | 204 | 0.140 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 376 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 1840 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2023 | 897 | 0.140 |
Why?
|
| Phenotype | 4 | 2018 | 6497 | 0.130 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 16 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2018 | 481 | 0.130 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 32 | 0.130 |
Why?
|
| Female | 22 | 2024 | 148644 | 0.130 |
Why?
|
| Enteritis | 1 | 2016 | 50 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 1099 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2019 | 728 | 0.130 |
Why?
|
| Chromatin | 1 | 2021 | 1043 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 594 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2022 | 613 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2016 | 187 | 0.120 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 1430 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 334 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2021 | 1626 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2019 | 266 | 0.120 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 151 | 0.120 |
Why?
|
| Adolescent | 13 | 2022 | 32671 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 1382 | 0.120 |
Why?
|
| Cell Line | 2 | 2021 | 5339 | 0.120 |
Why?
|
| Family | 1 | 2018 | 783 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 1122 | 0.110 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 189 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1726 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2019 | 5672 | 0.110 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 317 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2327 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 216 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2016 | 5438 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 2618 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 2355 | 0.100 |
Why?
|
| Inflammation | 2 | 2019 | 2512 | 0.100 |
Why?
|
| Young Adult | 9 | 2023 | 22152 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2021 | 1110 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 290 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2014 | 366 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2024 | 285 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 81 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 3944 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2018 | 6394 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 152 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 3398 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2018 | 1695 | 0.080 |
Why?
|
| Cytokines | 2 | 2021 | 2824 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 15191 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 965 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 2368 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 3149 | 0.080 |
Why?
|
| Enterobacteriaceae | 1 | 2008 | 54 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2008 | 74 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2024 | 33708 | 0.070 |
Why?
|
| Genitalia | 1 | 2016 | 47 | 0.070 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 165 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 4569 | 0.070 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 164 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2016 | 85 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 196 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 1135 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2016 | 222 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 999 | 0.070 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 188 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 366 | 0.060 |
Why?
|
| Education, Professional | 1 | 2005 | 13 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 45 | 0.060 |
Why?
|
| Ataxia | 1 | 2016 | 183 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 4251 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2023 | 39751 | 0.060 |
Why?
|
| Adult | 9 | 2023 | 81754 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2016 | 453 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 1462 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2017 | 270 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2017 | 757 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2017 | 652 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 35 | 0.050 |
Why?
|
| Cross Infection | 1 | 2008 | 547 | 0.050 |
Why?
|
| Metabolomics | 1 | 2017 | 505 | 0.050 |
Why?
|
| Biopsy | 2 | 2023 | 3387 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 62 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 69 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2012 | 1773 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2019 | 749 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 16 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 35 | 0.050 |
Why?
|
| Mitochondria | 1 | 2018 | 1300 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2022 | 4121 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 1023 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 464 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 656 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 301 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 349 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 669 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2022 | 428 | 0.040 |
Why?
|
| Busulfan | 1 | 2023 | 792 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 65 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 37 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 604 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 119 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 94 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 63 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 164 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 824 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 563 | 0.030 |
Why?
|
| Genomics | 2 | 2018 | 2836 | 0.030 |
Why?
|
| Unrelated Donors | 1 | 2018 | 321 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1475 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 425 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 4955 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 124 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 686 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 438 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 3242 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 173 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 687 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 152 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1502 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 1424 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 714 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 1371 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 1215 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 484 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 458 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 328 | 0.030 |
Why?
|
| Survival Rate | 2 | 2017 | 12513 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1182 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 2 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 717 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 738 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 201 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9466 | 0.030 |
Why?
|
| Incidence | 2 | 2018 | 5812 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 1586 | 0.020 |
Why?
|
| Prevalence | 2 | 2011 | 3357 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 196 | 0.020 |
Why?
|
| Middle Aged | 4 | 2022 | 90100 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 2364 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 2044 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 694 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 5001 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 588 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 1187 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1552 | 0.020 |
Why?
|
| United States | 1 | 2017 | 15856 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 2348 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1200 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 9041 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 18 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 35 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 13383 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 56 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 6685 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 247 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 5104 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 3592 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 2197 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 5462 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 3607 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 212 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6256 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 3164 | 0.020 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 1 | 0.020 |
Why?
|
| Infection Control | 1 | 2008 | 276 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10262 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 4648 | 0.020 |
Why?
|
| International Agencies | 1 | 2005 | 108 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 5758 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 2808 | 0.020 |
Why?
|
| Emergency Medicine | 1 | 2005 | 155 | 0.010 |
Why?
|
| Schools | 1 | 2005 | 238 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 796 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 22475 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2003 | 127 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 101 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 309 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 3471 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17849 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 913 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1237 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 12104 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 73175 | 0.010 |
Why?
|